Fangsheng pharmaceutical: RMB 176 million to acquire 100% equity of tengwangge pharmaceutical
Fangsheng pharmaceutical announced that the company signed equity transfer agreement with Boda development, yuanhuixuan consulting and changyixing investment, and transferred 100% equity of Jiangxi tengwangge Pharmaceutical Co., Ltd. with 176 million yuan. The core asset of tengwangge pharmaceutical is that it has 32 drug approval numbers (specifications) for all kinds of products with "tengwangge" as the registered trademark, mainly involving cough and phlegm relieving, heat clearing and detoxification, tonic, pediatric medicine, etc. This transaction will help the company expand the coverage of common diseases and commonly used drugs.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare, Financials
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”
May 12, 2022 05:41 PM
Briefing Updated 45 mins ago
· Healthcare
The shelter Hospital of Shanghai Shipbuilding Museum closed today
Apr 18, 2022 06:30 PM
Apr 22, 2021 03:11 PM
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Briefing Feb 10, 2022 02:09 PM
· Technology
Suzhou Keda: the impact of the "entity list" event has been basically eliminated
Briefing Oct 28, 2021 04:03 PM
· Technology
Dahua shares released Dahua think strategic # strategy
Briefing Jul 29, 2020 10:54 PM
· Technology
Dahua Technology Records NI Growth of 10.57% for First Half of 2020
Briefing Updated 14 hours ago
· Healthcare
15 shares were increased by land stock connect by more than 20%, and Zhongsheng pharmaceutical had the largest increase
See more
Read next
In-depth
In-depth
Healthcare, Financials
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
May 12, 2022 05:41 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.